Coverage of influenza vaccination of patients with diabetes and determination of barriers for implementation of vaccination
Abstract
People with diabetes (PWD) are considered to be at high risk of developing severe influenza complications that can lead to hospitalization and sometimes death. It is because of the high risk of developing severe complications that WHO recommends seasonal influenza vaccination (SIV) for PWD.
The purpose of the work is to establish the level of coverage of vaccination in PWD and to identify barriers to vaccination in this group in order to overcome obstacles.
We analyzed data on the coverage of SIV in PWD and studied the problems of low adherence to vaccination in PWD. We used content analysis, bibliosemantic, analytical, generalizing analyses. An insufficient level of vaccination coverage of PWD has been established. Barriers to vaccination in PWD have been identified. Barriers can be: age, health status, allergic reactions and chronic diseases of people, lower level of education, gender and their employment in economic activities. At the same time, gaps in the knowledge of health care provider, insufficient involvement of endocrinologists and diabetologists in informing PWD about vaccination, a limited number of imported vaccines, and low physical and economic accessibility of vaccines negatively affect the coverage of SIV. A significant factor influencing the level of vaccination coverage of people is their vaccination hesitation. Pharmacists should actively participate in the vaccination campaign by raising public awareness and providing advice to PWD who regularly visit pharmacies. To increase the vaccination coverage of PWD, it is necessary to introduce training programs for doctors and pharmacists to attract them to influenza vaccination companies. Simultaneously conduct educational campaigns and education of PWD. It is advisable to organize a free flu vaccination in medical and diagnostic diabetic hospital (institutions) to increase the physical and economic accessibility of vaccination for PWD. A large number of studies showing the cost-effectiveness of SIV in PWD should be a significant factor for health authorities to improve measures to increase the level of coverage of SIV in patients in this risk group.
References
WHO. Influenza: are we ready? – URL: https://www.who.int/news-room/spotlight/influenza-are-we-ready
Flu News Europe. Season overview. – URL: https://flunewseurope.org
Zakliuchna informatsiia shchodo pidsumkiv epidemichnoho sezonu z hrypu ta hostrykh respiratornykh infektsii 2021/2022 rokiv 20.06.2022. – URL: https://phc.org.ua/sites/default/files/users/user90/flu_operinfo_2021_2022_season.pdf
Centers for Disease Control and Prevention. (USA Department fo Health and Human Services). National Center for Immunization and Respiratory Diseases. People at High Risk of Flu, 2020. – URL: https://www.cdc.gov/vaccines/adults/rec-vac/healthconditions/diabetes/infographic/index.html
Mertz D., Kim T. H., Johnstone J. et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis // BMJ. – 2013. – V. 347. – Р. f5061. http://doi.org/10.1136/bmj.f5061
Herold K. C., Huen A., Gould L. et al. Alterations in lymphocyte subpopulations in type 1 (insulin-dependent) diabetes mellitus: exploration of possible mechanisms and relationships to autoimmune phenomena // Diabetologia. – 1984. – V. 27. – Р. 102–105. http://doi.org/10.1007/BF00275660
Philips B. J., Meguer J. X., Redman J., Baker E. H. Factors determining the appearance of glucose in upper and lower respiratory tract secretions // Intensive Care Med. – 2003. – V. 29 (12). – Р. 2204–2210. http://doi.org/10.1007/s00134-003-1961-2
Kohio H. P., Adamson A. L. Glycolytic control of vacuolartype ATPase activity: a mechanism to regulate influenza viral infection // Virology. – 2013. – V. 444 (1–2). – Р. 301–309. http://doi.org/10.1016/j.virol.2013.06.026
Garnett J. P., Baker E. H., Naik S. et al. Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose // Thorax. – 2013. – V. 68 (9). – Р. 835–845. http://doi.org/10.1136/thoraxjnl-2012-203178
CDC. Flu and people with diabetes. – URL: https://www.cdc.gov/flu/highrisk/ diabetes.htm
International Pharmaceutical Federation (FIP). Vaccination of special-risk groups: A toolkit for pharmacists. The Hague: FIP, 2022. – URL: https://www.fip.org/file/5380
The National Foundation for Infectious Diseases (US) provides information regarding vaccinations in diabetics. – URL: https://www.nfid.org/2020/11/05/for-patients-with-diabetes-flu-vaccination-is-more-important-than-ever/
Allard R., Leclerc P., Tremblay C., Tannenbaum T. N. Diabetes and the severity of pandemic influenza A (H1N1) infection // Diabetes Care. – 2010. – V. 33 (7). – Р. 1491–1493. http://doi.org/10.2337/dc09-2215
Casanova L., Gobin N., Villani P. et al. Bias in the measure of the effectiveness of seasonal influenza vaccination among diabetics // Prim Care Diabetes. – 2016. – V. 10. – Р. 398–406. http://doi.org/10.1016/j.pcd.2016.05.005
Remschmidt C., Wichmann O., Harder T. Vaccines for the prevention of seasonal influenza in patients with diabetes: systematic review and meta-analysis // BMC Med. – 2015. – V. 17 (13). – Р. 53. http://dx.doi.org/10.1186/s12916-015-0295-6
Joslin Diabetes Center.The Flu Shot and Diabetes. – URL: https://www.joslin.org/patient-care/diabetes-education/diabetes-learning-center/flu-shot-and-diabetes#.
Lee P. Y., Matchar D. B., Clements D. A. et al. Economic analysis of influenza vaccination and antiviral treat- ment for healthy working adults // Ann. Intern. Med. – 2002. – V. 137. – Р. 225–231. http://doi.org/10.7326/0003-4819-137-4-200208200-00005
Hryp ta hostri respiratorni infektsii klinichna nastanova, zasnovana na dokazakh (Onovlennia 2018). – URL: https://www.dec.gov.ua/wp-content/uploads/2019/11/2018_kn_gryp.pdf
WHO. Fact sheet on influenza. – WHO, 2014 – URL: http://www.who.int/mediacentre/factsheets/fs211/en/
American Diabetes Association, 4. Comprehensive medical evaluation and assessment of comorbidities: standards of medical care in Diabetes // Diabetes Care. – 2020. – V. 43 (1). – Р. 37–47.
Chomu potribno robyty shcheplennia vid hrypu: detalno pro naibilsh poshyrenu virusnu infektsiiu. – URL: ttps://solom.kyivcity.gov.ua/news/9706.html
WHO, Strategic Advisory Group of Experts (SAGE) Working Group. Background paper on influenza vaccines and immunization, 2012. – URL: http://www.who.int/entity/immunization/sage/meetings/2012/april/1_Background_Paper_Mar26_v13_cleaned.pdf?ua=1.
Zakliuchna informatsiia shchodo pidsumkiv epidemichnoho sezonu z hrypu ta hostrykh respiratornykh infektsii 2021/2022 rokiv tsentru hromadskoho zdorovia Ukrainy. – Kyiv, 2022. – 11s.
Rabbone I., Scaramuzza A., Iafusco D. et al. Pandemic influenza vaccination coverage in children with type 1 diabetes: analysis from seven Italian centers // Hum. Vaccin. – 2011. – V. 7. – Р. 1291–1292. https://doi.org/10.4161/hv.7.12.18335
Jimenez-Trujillo I., Jiménez-García R., Esteban-Hernández J. et al. Predictors of adherence to multiple clinical preventive recommendations among adults with diabetes in Spain // PLoS One. – 2016. – V. 10 (6). – e0131844. https://doi.org/10.1371/journal.pone.0160477
Moreno-Fernández J., García-Seco J., Rodrigo E. et al. Vaccination adherence to influenza, pneumococcal and hepatitis B virus in adult type 1 diabetes mellitus patients // Primary Care Diabetes. – 2020. – V. 14. – Р. 343–348. https://doi.org/10.1016/j.pcd.2019.09.004
Dallagiacoma G., Allora A., Salvati S. et al. Type 1 Diabetes Patients' Practice, Knowledge and Attitudes towards Influenza Immunization // Vaccines (Basel). – 2021. – V. 9 (7). – Р. 707. https://doi.org/10.3390/vaccines9070707.
Cocciolo G., Salvati S., Allora A. et al. Influenza vaccination coverage in patients with diabetes mellitus afferent to an Italian hospital // Eur. J. Public Health. – 2020. – V 30 (5). – URL: Artikler%20vak%20dia%2012112022/ckaa165.037.pdf
Yeluri S., Gara H., Vamsi G. et al. Health-care professional’s attitude, beliefs and perceived potential barriers for recommended adult immunization practices in patients with type-2 diabetes mellitus // Inter. J. Res. Med. Sci. – 2021. – V. 9 (1). – Р. 148–154. https://doi.org/10.18203/2320-6012.ijrms20205834
Sz˝oll˝osi G. J., Minh N. C., Pataki J. et al. Influenza Vaccination Coverage and Its Predictors among Self-Reported Diabetic Patients – Findings from the Hungarian Implementation of the European Health Interview Survey // Int. J. Environ. Res. Public Health. – 2022. – V. 19. – Р. 16289 (2–11). https://doi.org/10.3390/ijerph192316289
Blin А. Gestion, dispensation et administration des vaccins à l’officine // Actualités pharmaceutiques. – 2022. – V. 61. – P. 45–48. http://dx.doi.org/10.1016/j.actpha.2021.12.050
Verger P., Bocquier A., Vergélys C. et al. Flu vaccination among patients with diabetes: motives, perceptions, trust, and risk culture – a qualitative survey // BMC Public Health. – 2018. – V. 18. – Р. 569. https://doi.org/10.1186/s12889-018-5441-6
Oakley S., Bouchet J., Costello P., Parker J. Influenza vaccine uptake among at-risk adults (aged 16–64 years) in the UK: a retrospective database analysis // BMC Public Health. – 2021. – V. 21. – Р. 1734. https://doi.org/10.1186/s12889-021-11736-2
Modin D., Claggett B., Køber L. et al. Influenza Vaccination Is Associated With Reduced Cardiovascular Mortality in Adults With Diabetes: A Nationwide Cohort Study // Diabetes Care. –2020. – V. 43 (9). – Р. 2226–2233. https://doi.org/10.2337/dc20-0229
Han A. L. Factors associated with influenza vaccine coverage among patients with diabetes: Korea National Health and Nutrition Examination Survey 2016–2018 // Int. J. Diabetes Dev. Ctries. – 2022. – V. 42. – Р. 297–304. https://doi.org/10.1007/s13410-021-00977-x
Ciblak M. A. Influenza vaccination in Turkey: prevalence of risk groups, current vaccination status, factors influencing vaccine uptake and steps taken to increase vaccination rate // Vaccine. – 2013. – V. 31 (3). – Р. 518–523. https://doi.org/10.1016/j.vaccine.2012.11.022 PMID: 23174194
Sozen M., Karatoprak A., Demirhan Y. et al. Awareness of influenza and pneumococcal vaccines in diabetic patients // J. Diabetes & Metabolic Disorders. – 2021. – V. 20. – Р. 757–763. https://doi.org/10.1007/s40200-021-00812-4
Al Awaidy S., Al Slail F., Al Kathiry D. et al. A Case for Enhancing Coverage of Influenza Vaccination in Gulf Cooperation Council Countries in Patients with Diabetes Mellitus during COVID-19 // Oman Med. J. – 2021. – V. 36 (6). – e325. https://doi.org/10.5001/omj.2021.132
Pangrazzi L., Weinberger B. T cells, aging and senescence // Exp. Gerontol. – 2020. – V. 134. – Р. 110887. https://doi.org/10.1016/j.exger.2020.110887
Crooke S. N., Ovsyannikova I. G., Poland G. A., Kennedy R. B. Immunosenescence and human vaccine immune responses // Immun. Ageing. – 2019. – V. 16. – Р. 1–16. https://doi.org/10.1186/s12979-019-0164-9
Al-Sofiani M., Ganji S. S., Kalyani R. R. Body composition changes in diabetes and aging // J. Diabetes Complicat. – 2019. – V. 33. – Р. 451–459. https://doi.org/10.1016/j.jdiacomp.2019.03.007
Kwetkat A., Heppner H. J. Comorbidities in the Elderly and Their Possible Influence on Vaccine Response // Interdiscip. Top. Gerontol. Geriatr. – 2020. – V. 43. – Р. 73–85. https://doi.org/10.1159/000504491
Bianchi F. P., Tafuri S. Vaccination of Elderly People Affected by Chronic Diseases: A Challenge for Public Health // Vaccines. – 2022. – V. 10. – Р. 641. https://doi.org/10.3390/vaccines10050641
Zhang Y. Y., Tang X. F., Du C. H. et al. Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis // Hum. Vaccin. Immunother. – 2016. – V. 12. – Р. 3056–3064, http://dx.doi.org/10.1080/21645515.2016.1221552
Peasah S. K., Azziz-Baumgartner E., Breese J. et al. Influenza cost and costeffectiveness studies globally – a review // Vaccine. – 2013. – V. 31 (46). – Р. 5339–5348. https://doi.org/10. 1016/j.vaccine.2013.09.013
Akın L., Macabéo B., Caliskan Z. et al. Cost-Effectiveness of Increasing Influenza Vaccination Coverage in Adults with Type 2 Diabetes in Turkey // PLoS ONE. – 2016. – V. 11 (6). – e0157657. https://doi.org/10.1371/journal.pone.0157657
Lewing B. D., Wallick C., To T. M. et al. Short and long-term impact of influenza infection on individuals with type 2 diabetes: Effect on healthcare utilization and diabetes complications // Diabetes Management. – 2021. – V. 11 (2). – Р. 171–179.
Dos Santos G., Tahrat H., Bekkat-Berkani R. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: a systematic review // Hum. Vaccin Immunother. – 2018. – V. 14. – Р. 1853–1866. https://doi.org/10.1080/21645515.2018.1446719
Pandemic Influenza Preparedness Framework: progress report, 1 January–30 June 2022. Geneva: WHO; 2022. Licence: CC BY-NC-SA 3.0 IGO. – URL: https://www.who.int/health-topics/influenza-seasonal#tab=tab_1
Vamos E., Pape U., Curcin V. et al. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes // CMAJ. – 2016. – V. 188 (14). – Р. E342–E351. https://doi.org/10.1503/cmaj.151059
Gupta C., Sachdeva A., Khamar J. et al. Effectiveness of the influenza vaccine at reducing adverse events in patients with heart failure: A systematic review and meta-analysis // Vaccine. – 2022. – V. 40 (25). – Р. 3433–3443. https://doi.org/10.1016/j.vaccine.2022.04.039
Puri N., Coomes E. A., Haghbayan H. et al. Social media and vaccine hesitancy: new updates for the era of COVID-19 and globalized infectious diseases // Hum. Vaccin Immunother. – 2020. – V. 16 (11). – Р. 2586–2593. https://doi.org/10.1080/21645515.2020.1780846
WHO. Immunizing the Public Against Misinformation [Internet]. 2020. updated 2021. – URL: https://www.who.int/news-room/feature-stories/detail/immunizing-the-public-against-misinformation
Bocquier A., Cortaredona S., Fressard L. Seasonal influenza vaccination among people with diabetes: influence of patients’ characteristics and healthcare use on behavioral changes // Human Vaccines & Іmmunotherapeutics. – 2020. – V. 16 (10). – Р. 2565–2572. https://doi.org/10.1080/21645515.2020.1729628
WHO. Influenza: are we ready? – URL: https://www.who.int/ru/news-room/spotlight/spotlight
United Nations Children’s Fund. Vaccine Misinformation Management Field Guide, 2020. – URL: https://www. unicef.org/mena/reports/vaccine-misinformation-management-field-guide
International Pharmaceutical Federation and WHO. Good Pharmacy Pracice: Joint FIP/ WHO Guidelines on GPP – Standards for quality of pharmacy services. 2011. – URL: https://www.fip.org/files/fip/WHO/ GPP%20guidelines%20FIP%20publication_final.pdf,
International Pharmaceutical Federation. An overview of current pharmacy impact on immunisation: A global report, 2016. – URL: https://www.fip.org/file/162
International Pharmaceutical Federation. An overview of pharmacy’s impact on immunisation coverage. A global survey, 2021. – URL: https://www.fip.org/file/4751
This work is licensed under a Creative Commons Attribution 4.0 International License.
